Showing 21 - 40 results of 597 for search '"prostate cancer"', query time: 0.06s Refine Results
  1. 21
  2. 22

    Oxidative Stress and DNA Methylation in Prostate Cancer by Krishna Vanaja Donkena, Charles Y. F. Young, Donald J. Tindall

    Published 2010-01-01
    “…The protective effects of fruits, vegetables, and other foods on prostate cancer may be due to their antioxidant properties. …”
    Get full text
    Article
  3. 23

    XMRV Discovery and Prostate Cancer-Related Research by David E. Kang, Michael C. Lee, Jaydip Das Gupta, Eric A. Klein, Robert H. Silverman

    Published 2011-01-01
    “…Xenotropic murine leukemia virus-related virus (XMRV) was first reported in 2006 in a study of human prostate cancer patients with genetic variants of the antiviral enzyme, RNase L. …”
    Get full text
    Article
  4. 24

    Brachytherapy for Prostate Cancer: A Systematic Review by Georgios Koukourakis, Nikolaos Kelekis, Vassilios Armonis, Vassilios Kouloulias

    Published 2009-01-01
    “…Low-dose rate brachytherapy has become a mainstream treatment option for men diagnosed with prostate cancer because of excellent long-term treatment outcomes in low-, intermediate-, and high-risk patients. …”
    Get full text
    Article
  5. 25

    HTA and Reimbursement Status of Metastatic Hormone‑Sensitive Prostate Cancer, Non-Metastatic Castration-Resistant Prostate Cancer, and Metastatic Castration-Resistant Prostate Cancer Treatments in Europe: A Patient Access Landscape Review by Goran Bencina, Elina Petrova, Demet Sönmez, Sonia Matos Pereira, Ioannis Dimitriadis, Stina Salomonsson

    Published 2023-06-01
    “…Recently, novel therapies have received regulatory approval with significant improvement in overall survival for metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, and nonmetastatic castration-resistant prostate cancer. …”
    Get full text
    Article
  6. 26

    The Current Role of Osteoclast Inhibitors in Patients with Prostate Cancer by Diomidis Kozyrakis, Dionyssios Paridis, Stefanos Perikleous, Konstantinos Malizos, Anastasios Zarkadas, Antonios Tsagkalis

    Published 2018-01-01
    “…Purpose. Prostate cancer (PCa) is one of the most frequently diagnosed malignancies worldwide. …”
    Get full text
    Article
  7. 27

    Glucose Metabolism of Human Prostate Cancer Mouse Xenografts by Hossein Jadvar, Xiankui Li, Antranik Shahinian, Ryan Park, Michel Tohme, Jacek Pinski, Peter S. Conti

    Published 2005-04-01
    “…We hypothesized that the glucose metabolism of prostate cancer is modulated by androgen. We performed in vivo biodistribution and imaging studies of [F-18] fluorodeoxyglucose (FDG) accumulation in androgen-sensitive (CWR-22) and androgen-independent (PC-3) human prostate cancer xenografts implanted in castrated and noncastrated male athymic mice. …”
    Get full text
    Article
  8. 28

    GILT stabilizes cofilin to promote the metastasis of prostate cancer by Dunsheng Han, Zhiming Wu, Cong Zhang, Ziwei Wei, Fan Chao, Xuefeng Xie, Jinke Liu, Yufeng Song, Xiaoming Song, Dingchang Shao, Shiyu Wang, Guoxiong Xu, Gang Chen

    Published 2025-01-01
    “…While the involvement of GILT in the development of various tumors has been demonstrated, the mechanisms underlying its regulation in prostate cancer (PCa) are not fully understood. In the present study, we confirmed that GILT was significantly upregulated in PCa and facilitated tumor metastasis. …”
    Get full text
    Article
  9. 29
  10. 30
  11. 31

    New Therapeutics to Treat Castrate-Resistant Prostate Cancer by Ömer Acar, Tarık Esen, Nathan A. Lack

    Published 2013-01-01
    “…The effective treatment of castrate-resistant prostate cancer (CRPC) has proven to be very challenging. …”
    Get full text
    Article
  12. 32

    A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago by Ian Hosein, Rajendra Sukhraj, Lester Goetz, Nastassia Rambarran, Satyendra Persaud

    Published 2016-01-01
    “…Afro-Trinidadians comprised a disproportionate number of those diagnosed with prostate cancer and had a greater risk of high risk disease.…”
    Get full text
    Article
  13. 33

    HDR Brachytherapy in the Management of High-Risk Prostate Cancer by Susan Masson, Raj Persad, Amit Bahl

    Published 2012-01-01
    “…This approach is particularly favourable in prostate cancer where tumours are highly sensitive to dose escalation and to increases in radiotherapy fraction size, due to the unique radiobiological behaviour of prostate cancers in contrast with other malignancies. …”
    Get full text
    Article
  14. 34

    Considerations on the use of Diagnostic Tools in the Prevention of Prostate Cancer by Juan Santiago Serna Trejos, Stefanya Geraldine Bermúdez Moyano

    Published 2022-10-01
    “…The therapeutic approach in the prevention of prostate cancer is a clinical challenge for the health professional who is preparing to face this condition. …”
    Get full text
    Article
  15. 35

    MR-Guided Adaptive Radiotherapy in Localized Prostate Cancer by Andrea Gaetano Allegra MD, Luca Nicosia MD, Michele Rigo MD, Nicola Bianchi BS, Riccardo Filippo Borgese BS, Antonio De Simone BS, Niccolò Giaj-Levra PhD, Davide Gurrera BS, Stefania Naccarato BS, Edoardo Pastorello MD, Francesco Ricchetti MD, Gianluisa Sicignano BS, Ruggero Ruggieri BS, Filippo Alongi MD

    Published 2025-01-01
    “…This modality is possible due to dedicated systems consisting of a MR scanner mounted on a conventional linac and software that permit daily online treatment plan adaptation. Prostate cancer (PC) is one of the most common malignancies in RO clinical practice and currently under investigation with this new technology. …”
    Get full text
    Article
  16. 36

    Radical Prostatectomy: An Option for High-Risk Prostate Cancer by S. Rausch, C. Schmitt, T. Kälble

    Published 2012-01-01
    “…Introduction. High-risk prostate cancer represents a therapeutic challenge. The role of radical prostatectomy (RP) in patients with extreme PSA values is under discussion. …”
    Get full text
    Article
  17. 37

    Radiotherapeutic Strategies in the Management of Low-Risk Prostate Cancer by Kevin S. Choe, Stanley L. Liauw

    Published 2010-01-01
    “…Prostate cancer is the most common nonskin malignancy among men in the United States. …”
    Get full text
    Article
  18. 38
  19. 39
  20. 40

    Radiotherapy for Oligometastases and Oligo-Recurrence of Bone in Prostate Cancer by Ken-ichi Tabata, Yuzuru Niibe, Takefumi Satoh, Hideyasu Tsumura, Masaomi Ikeda, Satoru Minamida, Tetsuo Fujita, Daisuke Ishii, Masatsugu Iwamura, Kazushige Hayakawa, Shiro Baba

    Published 2012-01-01
    “…To retrospectively evaluate the clinical significance of radiotherapy for oligometastases of bone in prostate cancer (PCa). Methods and Materials. Between 2003 and 2008, 35 PCa patients with oligometastases of bone were treated with radiotherapy. …”
    Get full text
    Article